The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells
Cancer Informatics · 2015-01 · 14s4 · CIN.S19338
DOI: 10.4137/cin.s19338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Informatics, online erschienen am 15.07.2015. Verfasst von Shannon M Mumenthaler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Applied Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Therapeutic resistance arises as a result of evolutionary processes driven by dynamic feedback between a heterogeneous cell population and environmental selective pressures. Previous studies have suggested that mutations conferring resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in non-small-cell lung cancer (NSCLC) cells lower the fitness of resistant cells relative to drug-sensitive cells in a drug-free environment. Here, we hypothesize that the local tumor microenvironment could influence the magnitude and directionality of the selective effect, both in the presence and absence of a drug. Using a combined experimental and computational approach, we developed a mathematical model of preexisting drug resistance describing multiple cellular compartments, each representing a specific tumor environmental niche. This model was parameterized using a novel experimental dataset derived from the HCC827 erlotinib-sensitive and -resistant NSCLC cell lines. We found that, in contrast to in the drug-free environment, resistant cells may hold a fitness advantage compared to parental cells in microenvironments deficient in oxygen and nutrients. We then utilized the model to predict the impact of drug and nutrient gradients on tumor composition and recurrence times, demonstrating that these endpoints are strongly dependent on the microenvironment. Our interdisciplinary approach provides a model system to quantitatively investigate the impact of microenvironmental effects on the evolutionary dynamics of tumor cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Applied Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- School of Mathematics, University of Minnesota, Minneapolis, MN, USA.
- Department of Industrial and Systems Engineering, University of Minnesota, Minneapolis, MN, USA.
- Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
- Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Palo Alto, CA, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Mumenthaler, S. M., Foo, J., Choi, N. C., Heise, N., Leder, K., Agus, D. B., Pao, W., Michor, F., & Mallick, P. (2015). The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells. Cancer Informatics, 14s4, CIN.S19338. https://doi.org/10.4137/cin.s19338
Vancouver
Mumenthaler SM, Foo J, Choi NC, Heise N, Leder K, Agus DB, et al. The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells. Cancer Informatics. 2015;14s4:CIN.S19338. doi:10.4137/cin.s19338
BibTeX
@article{Mumenthaler2015,
author = {Mumenthaler, Shannon M and Foo, Jasmine and Choi, Nathan C and Heise, Nicholas and Leder, Kevin and Agus, David B and Pao, William and Michor, Franziska and Mallick, Parag},
title = {The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells},
journal = {Cancer Informatics},
year = {2015},
volume = {14s4},
pages = {CIN.S19338},
doi = {10.4137/cin.s19338}
}
EUVIMED